Osel, Inc.
Patent Owner
Stats
- 10 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Feb 04, 2014 most recent publication
Details
- 10 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 239 Total Citation Count
- Apr 11, 1997 Earliest Filing
- 4 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
7833791 Lactobacilli expressing biologically active polypeptides and uses thereofNov 09, 07Nov 16, 10[C12N]
7754467 Surface expression of biologically active proteins in bacteriaJan 28, 04Jul 13, 10[A61K, C12N, C07K]
7312076 Lactobacilli expressing biologically active polypeptides and uses thereofJan 05, 07Dec 25, 07[C12N]
6365156 Method for improving the half-life of soluble viral-specific ligands on mucosal membranesApr 14, 00Apr 02, 02[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2011/0066,137 APPLICATOR FOR APPLYING POWDER FORMULATIONS AND USES THEREOFAbandonedDec 17, 08Mar 17, 11[A61M]
2009/0155,304 Modified Cyanovirin-N PolypeptideAbandonedNov 24, 08Jun 18, 09[A61K, C12P, C12N, C07K]
7179458 Lactobacilli expressing biologically active polypeptides and uses thereofExpiredMar 06, 03Feb 20, 07[A01N]
2002/0086,020 Method for improving the half-life of soluble viral receptors on mucosal membranesAbandonedJan 10, 02Jul 04, 02[A61K, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.